OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 93 citing articles:

Role of inflammatory signaling in atrial fibrillation
Larry Scott, Na Li, Dobromir Dobrev
International Journal of Cardiology (2018) Vol. 287, pp. 195-200
Open Access | Times Cited: 147

Oxidative Stress and Renal Fibrosis: Recent Insights for the Development of Novel Therapeutic Strategies
Wenshan Lv, George W. Booz, Fan Fan, et al.
Frontiers in Physiology (2018) Vol. 9
Open Access | Times Cited: 128

Inflammasomes and Proteostasis Novel Molecular Mechanisms Associated With Atrial Fibrillation
Na Li, Bianca J.J.M. Brundel
Circulation Research (2020) Vol. 127, Iss. 1, pp. 73-90
Open Access | Times Cited: 83

Adipokines and Inflammation: Focus on Cardiovascular Diseases
Sandra Feijóo‐Bandín, Alana Aragón‐Herrera, Sandra Moraña‐Fernández, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 20, pp. 7711-7711
Open Access | Times Cited: 78

Targeting the NLRP3 inflammasome to treat cardiovascular fibrosis
Anita A. Pinar, Tara Scott, Brooke M. Huuskes, et al.
Pharmacology & Therapeutics (2020) Vol. 209, pp. 107511-107511
Closed Access | Times Cited: 77

Chronic low‐grade inflammation in heart failure with preserved ejection fraction
Thássio Mesquita, Yen‐Nien Lin, Ahmed Ibrahim
Aging Cell (2021) Vol. 20, Iss. 9
Open Access | Times Cited: 57

Cardiomyocyte Inflammasome Signaling in Cardiomyopathies and Atrial Fibrillation: Mechanisms and Potential Therapeutic Implications
Gong Chen, Mihail G. Chelu, Dobromir Dobrev, et al.
Frontiers in Physiology (2018) Vol. 9
Open Access | Times Cited: 67

Ghrelin protects the heart against ischemia/reperfusion injury via inhibition of TLR4/NLRP3 inflammasome pathway
Qin Wang, Ping‐I Lin, Li Peng, et al.
Life Sciences (2017) Vol. 186, pp. 50-58
Closed Access | Times Cited: 64

Relaxin and extracellular matrix remodeling: Mechanisms and signaling pathways
Hooi Hooi Ng, Matthew Shen, Chrishan S. Samuel, et al.
Molecular and Cellular Endocrinology (2019) Vol. 487, pp. 59-65
Open Access | Times Cited: 58

Beauty and the beast: host microRNA-155 versus SARS-CoV-2
Konstantinos I. Papadopoulos, Alexandra Papadopoulou, Tar Choon Aw
Human Cell (2023) Vol. 36, Iss. 3, pp. 908-922
Open Access | Times Cited: 21

Polydatin Protects Diabetic Heart against Ischemia‐Reperfusion Injury via Notch1/Hes1‐Mediated Activation of Pten/Akt Signaling
Liming Yu, Zhi Li, Xue Dong, et al.
Oxidative Medicine and Cellular Longevity (2018) Vol. 2018, Iss. 1
Open Access | Times Cited: 54

Cardioprotective actions of relaxin
Brian Martin, Guillermo Romero, Guy Salama
Molecular and Cellular Endocrinology (2019) Vol. 487, pp. 45-53
Open Access | Times Cited: 52

Serelaxin inhibits the profibrotic TGF‐β1/IL‐1β axis by targeting TLR‐4 and the NLRP3 inflammasome in cardiac myofibroblasts
Felipe Tapia Cáceres, Tracey A. Gaspari, Chrishan S. Samuel, et al.
The FASEB Journal (2019) Vol. 33, Iss. 12, pp. 14717-14733
Open Access | Times Cited: 45

The Role of Pyroptosis in Ischemic and Reperfusion Injury of the Heart
С. В. Попов, Л. Н. Маслов, N. V. Naryzhnaya, et al.
Journal of Cardiovascular Pharmacology and Therapeutics (2021) Vol. 26, Iss. 6, pp. 562-574
Open Access | Times Cited: 33

Research progress on the effects of novel hypoglycemic drugs in diabetes combined with myocardial ischemia/reperfusion injury
Tiangui Yang, Daqing Zhang
Ageing Research Reviews (2023) Vol. 86, pp. 101884-101884
Closed Access | Times Cited: 13

mir-605-3p prevents liver premetastatic niche formation by inhibiting angiogenesis via decreasing exosomal nos3 release in gastric cancer
Yilin Hu, Weijie Zang, Ying Feng, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5

Protective mechanism of safflower yellow injection on myocardial ischemia-reperfusion injury in rats by activating NLRP3 inflammasome
Lingmei Li, Ce Cao, Hao Guo, et al.
BMC Complementary Medicine and Therapies (2025) Vol. 25, Iss. 1
Open Access

Pepducin-mediated cardioprotection via β-arrestin-biased β2-adrenergic receptor-specific signaling
Laurel A. Grisanti, Toby P. Thomas, Rhonda L. Carter, et al.
Theranostics (2018) Vol. 8, Iss. 17, pp. 4664-4678
Open Access | Times Cited: 42

Serelaxin improves cardiac and renal function in DOCA-salt hypertensive rats
Dong Wang, Yuhuan Luo, Komuraiah Myakala, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 39

Sirt1 Activation by Post-ischemic Treatment With Lumbrokinase Protects Against Myocardial Ischemia-Reperfusion Injury
Yi-Hsin Wang, Shun-An Li, Chao-Hsin Huang, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 36

The Inflammasomes in Cardiovascular Disease
Gerardus P. J. van Hout, Lena Bosch
Experientia supplementum (2018), pp. 9-40
Closed Access | Times Cited: 35

Gold nanoparticles synthesized from Euphorbia fischeriana root by green route method alleviates the isoprenaline hydrochloride induced myocardial infarction in rats
Tipeng Zhang, Minyan Dang, Wenzhi Zhang, et al.
Journal of Photochemistry and Photobiology B Biology (2019) Vol. 202, pp. 111705-111705
Closed Access | Times Cited: 35

Relaxin mitigates microvascular damage and inflammation following cardiac ischemia–reperfusion
Xiao‐Ming Gao, Yidan Su, Shirley Moore, et al.
Basic Research in Cardiology (2019) Vol. 114, Iss. 4
Closed Access | Times Cited: 34

Page 1 - Next Page

Scroll to top